ICMR said that it has noticed that the BHU's authors have acknowledged ICMR in similar previous papers without permission. It has asked for an explanation on why ICMR should not seek legal and administrative action against the authors. The BHU said it is aware of the communication made by the ICMR to the individuals concerned and its Institute of Medical Sciences is looking into the matter. The university also added that it is working on improving its research ecosystem
The man's hypervaccination came to light when the public prosecutor in Magdeburg launched an investigation into the matter, suspecting fraudulent activity.
It is reasonable to expect the government to seriously consider honouring Poonawalla with Bharat Ratna, Pawar said.
Some public health agencies took years to admit what had quickly become obvious: that the COVID virus was airborne. Others suggested extreme precautions, which had minimal benefits or were hard to implement. Rebuilding trust is not just about clearer, more persuasive communication but also admitting to mistakes
Slow public procurement of COVID-19 vaccines has meant that the only way those eligible can avail the booster is by paying at private hospitals, leading to very low demand for precautionary doses despite rising cases.
The state does not have any vaccine left since February this year, Odisha director of family welfare Bijay Panigrahi wrote, and requested for at least 50,000 doses of CorBEvax vaccine with long expiry as early as possible.
He underscored that the current spike was noticed in those parts of the country which were the worst affected when the coronavirus caused a global pandemic.
The Union minister also said a review of data generated on the subject is being conducted by AIIMS, Delhi, and the report should be out soon.
People in their 50s, 40s, 30s, even 20s are being diagnosed with blocked arteries and heart problems. It's important to know the symptoms of heart attack, how to differentiate between different types of chest pain, and what to do if you experience pain that radiates up to your jaw and/or arms.
"A Lancet modelling study estimates that in India around 34,22,00054 deaths were prevented by vaccination in the year 2021, an estimate based on officially reported deaths in India," the report has said.
He was speaking on the sidelines of an event here at which a bilateral agreement was signed between the University of Wisconsin (UW)-Madison Global Health Institute (GHI) and the Ella Foundation for the establishment of the first-ever UW-Madison One Health Centre in Bengaluru.
A treatment that's more effective would be a huge advance. It’s time to put real resources into developing vaccines that offer longer-term protection
Tagging a video of Pfizer CEO Albert Bourla's encounter with a journalist in Davos, Chandrasekhar said on Twitter that the pharmaceutical company tried to bully the Indian government into accepting conditions of indemnity.
Due to lack of rise in demand for booster doses, small private hospitals have showed no interest in procuring the vaccine despite the ease of administration it promises, say industry sources
The vaccine, sold under brand name Covaxin, showed an immune response in individuals who had not received a COVID vaccine previously as well as those vaccinated with mRNA vaccines by Pfizer Inc and Moderna Inc, meeting its main goals, Ocugen said.
Covaxin was found to be well-tolerated in vaccine-naïve individuals and in individuals previously vaccinated with mRNA vaccines in the US with no vaccine-related serious adverse events, Bharat Biotech’s partner in the country has announced
As Covid gets back on the radar with a surge in China and people worry about another wave in India and whether the government should now allow a second booster shot to add to the two-jab protection, some scientists call for a reality check.
The needle-free vaccine will be available at private hospitals as of now and can be administered as a precaution dose to adults who have been vaccinated with two doses of either Covishield or Covaxin.
The Hyderabad-based Covaxin maker’s nasal vaccine will be introduced on Co-WIN by next week, sources said, adding that the pricing is yet to be decided
COVID-19: Even though the explosion of coronavirus cases in China has triggered global concerns, India has maintained that there is no need to panic in view of the extensive vaccine coverage. The government has, however, urged people to stay alert and follow COVID-appropriate behaviour
No other details were available on the timing and size of the delivery, although the spokesperson said Berlin is pushing for foreigners other than German citizens to be allowed access to the shot if they want it.
The Union health minister on December 21 reviewed the COVID-19 situation in the country and asked people to follow COVID-appropriate behaviour, including wearing masks in crowded places, and getting vaccinated.
The head of the panel of 18 appointees, known as STIKO, said there was no clear case for broad use, citing a lack of data to rule out any rare side effects and no signs of the infection causing severe illness in otherwise healthy children.
Narayana Murthy said in his speech announcing the winners of the Infosys Science Prize that the IITs have become victims of the syndrome of rote learning due to the tyranny of coaching classes.
China’s National Medical Products Administration approved CanSino’s Ad5-nCoV for emergency use as a booster vaccine, the company said in a statement to the Hong Kong Stock Exchange on Sunday.